Structure and Function of Purified Monoclonal Antibody Dimers Induced by Different Stress Conditions (Q57665607)

3

0 references

author name string

Rajsekhar Paul

1

0 references

Alexandra Graff-Meyer

2

0 references

Arne C. Rufer

5

0 references

Hermann Beck

6

0 references

Alexandre Briguet

7

0 references

Volker Schnaible

8

0 references

Thomas Buckel

9

0 references

Sabine Boeckle

Structure-immunogenicity relationships of therapeutic proteins

10

0 references

publication date

5 April 2012

0 references

published in

Pharmaceutical Research

0 references

volume

29

0 references

issue

8

0 references

page(s)

2047-2059

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Effects of protein aggregates: an immunologic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Coupling of aggregation and immunogenicity in biotherapeutics: T- and B-cell immune epitopes may contain aggregation-prone regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Is any measurement method optimal for all aggregate sizes and types?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Evaluation of a dual-wavelength size exclusion HPLC method with improved sensitivity to detect protein aggregates and its use to better characterize degradation pathways of an IgG1 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Distinct aggregation mechanisms of monoclonal antibody under thermal and freeze-thaw stresses revealed by hydrogen exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Protein aggregation and bioprocessing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Elucidation of two major aggregation pathways in an IgG2 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Protein aggregation: pathways, induction factors and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Classification and characterization of therapeutic antibody aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Active dimer of Epratuzumab provides insight into the complex nature of an antibody aggregate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Conformational implications of an inversed pH-dependent antibody aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Precise determination of the helical repeat of tobacco mosaic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

EMAN: semiautomated software for high-resolution single-particle reconstructions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Investigation of degradation processes in IgG1 monoclonal antibodies by limited proteolysis coupled with weak cation-exchange HPLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Crystallographic structure of an intact IgG1 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Immunoglobulin structure and function as revealed by electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Freezing immunoglobulins to see them move

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

New methods allowing the detection of protein aggregates: a case study on trastuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Modulation of antigenicity related to changes in antibody flexibility upon lyophilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Kinetics and thermodynamics of dimer formation and dissociation for a recombinant humanized monoclonal antibody to vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous beta1, 4-N-acetylglucosaminyltransferase III and Golgi alpha-mannosidase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Acid-induced aggregation of human monoclonal IgG1 and IgG2: molecular mechanism and the effect of solution composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Heterogeneity of monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Protect from light: photodegradation and protein biologics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

In vivo deamidation characterization of monoclonal antibody by LC/MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Antibody Response to Aggregated Human Interferon Alpha2b in Wild-type and Transgenic Immune Tolerant Mice Depends on Type and Level of Aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0732-6

Immunogenicity of aggregates of recombinant human growth hormone in mouse models

21 January 2018

1 reference

12 December 2020

Flexibility of human IgG subclasses

1 reference

12 December 2020

Shaken, not stirred: mechanical stress testing of an IgG1 antibody

1 reference

12 December 2020

Induction and analysis of aggregates in a liquid IgG1-antibody formulation

1 reference

12 December 2020

Aggregated recombinant human interferon Beta induces antibodies but no memory in immune-tolerant transgenic mice.

1 reference

12 December 2020

Examination of the secondary structure of proteins by deconvolved FTIR spectra

1 reference

12 December 2020

Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress

1 reference

12 December 2020

Kinetics of Low pH Induced Aggregation of Equine IgG

1 reference

12 December 2020

Protein secondary structures in water from second-derivative amide I infrared spectra

1 reference

12 December 2020

Characterization of the photodegradation of a human IgG1 monoclonal antibody formulated as a high-concentration liquid dosage form

1 reference

12 December 2020

Sub-visible particle quantitation in protein therapeutics

1 reference

12 December 2020

Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation

1 reference

12 December 2020